ADAG Adagene Inc.
$3.94 +11.79%
Healthcare · Pharmaceutical Preparations
Adagene Inc. (ADAG) is a healthcare company in the Pharmaceutical Preparations industry. Shares last traded at $3.94, 16.3% below their 52-week high. Over the past year the stock is up 141.4%. Net profit margin is -229.6%, below the peer median of -0.1%. Revenue grew 7332.8% year over year.
Market Cap
—
Shares Out
—
EPS (TTM)
$-0.30
P/E Ratio
—
P/S Ratio
—
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$4.70
52-Week Low
$1.33
Volume
5,636
Avg Vol (3m)
6,311.841
Performance
1W
+9.92%
1M
+15.06%
3M
+5.50%
6M
+118.61%
YTD
+121.07%
1Y
+141.41%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
58.93
SMA (50)
$3.66
SMA (200)
$2.72
Price vs SMA50
+7.38%
Price vs SMA200
+44.78%
ATR (14)
$0.24
Financials
Revenue
$8M
Net Income
$-18M
Gross Margin
—
Operating Margin
-279.5%
Net Margin
-229.6%
Return on Equity
-49.8%
Return on Assets
-22.5%
Current Ratio
3.07
Debt / Equity
0.03
Revenue Growth (YoY)
+7332.8%
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Pharmaceutical Preparations peers
ADAG vs 14 industry peers (Pharmaceutical Preparations), by market cap.
1–14 of 14
| LLY | Lilly (Eli) | $1.04T | 50.16 | 15.88 | 31.7% | -1.17% |
| JNJ | Johnson & Johnson | $549.8B | 20.51 | 5.84 | 28.5% | -2.42% |
| ONC | Beone Medicines Ltd. | $390.6B | 1361.26 | 73.10 | 5.4% | +2.83% |
| ABBV | AbbVie | $382.5B | 90.51 | 6.25 | 6.9% | -2.16% |
| MRK | Merck | $281.6B | 15.43 | 4.33 | 28.1% | -1.30% |
| ABT | Abbott Laboratories | $154.3B | 23.65 | 3.48 | 14.7% | +0.09% |
| PFE | Pfizer | $143.7B | 18.50 | 2.30 | 12.4% | -2.89% |
| VRTX | Vertex Pharmaceuticals | $114.6B | 28.99 | 9.55 | 32.9% | -1.63% |
| BMY | Bristol Myers Squibb | $110.3B | 15.63 | 2.29 | 14.6% | -2.35% |
| REGN | Regeneron Pharmaceuticals | $63.4B | 14.08 | 4.42 | 31.4% | +0.38% |
| ALNY | Alnylam Pharmaceuticals | $36.9B | 117.57 | 9.93 | 8.4% | -1.66% |
| TEVA | Teva Pharmaceutical Industries Ltd | $36.6B | 25.98 | 2.12 | 8.2% | -3.33% |
| ZTS | Zoetis | $33.1B | 12.37 | 3.49 | 28.2% | +2.09% |
| RPRX | Royalty Pharma Plc | $23.1B | 30.02 | 9.73 | 32.4% | -1.30% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.